$300 Million is the total value of BRIDGER MANAGEMENT, LLC's 29 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UBER | Sell | UBER TECHNOLOGIES INC | $34,301,026 | +26.5% | 794,557 | -7.1% | 11.42% | +12.9% |
| MLCO | Buy | MELCO RESORTS AND ENTMNT LTDadr | $23,994,140 | +10.6% | 1,965,122 | +15.3% | 7.99% | -1.3% |
| CZR | CAESARS ENTERTAINMENT INC NE | $23,676,839 | +4.4% | 464,525 | 0.0% | 7.88% | -6.8% | |
| GDDY | Sell | GODADDY INCcl a | $20,270,299 | -11.0% | 269,803 | -7.9% | 6.75% | -20.5% |
| CHTR | CHARTER COMMUNICATIONS INC Ncl a | $18,703,909 | +2.7% | 50,913 | 0.0% | 6.23% | -8.3% | |
| MS | Sell | MORGAN STANLEY | $15,535,456 | -27.6% | 181,914 | -25.5% | 5.17% | -35.3% |
| ALC | Buy | ALCON AG | $14,942,131 | +30.4% | 181,977 | +12.0% | 4.98% | +16.4% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $14,920,984 | – | 42,400 | +100.0% | 4.97% | – |
| New | BATH & BODY WORKS INC | $13,953,750 | – | 372,100 | +100.0% | 4.65% | – | |
| BIIB | Sell | BIOGEN INC | $13,283,410 | -15.1% | 46,633 | -17.1% | 4.42% | -24.2% |
| LLY | New | LILLY ELI & CO | $13,167,082 | – | 28,076 | +100.0% | 4.38% | – |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12,393,420 | -10.9% | 142,979 | 0.0% | 4.13% | -20.4% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $11,295,000 | -14.9% | 1,500,000 | 0.0% | 3.76% | -24.1% | |
| USFD | New | US FOODS HLDG CORP | $10,842,964 | – | 246,431 | +100.0% | 3.61% | – |
| CTLT | New | CATALENT INC | $10,464,416 | – | 241,338 | +100.0% | 3.48% | – |
| IMGN | New | IMMUNOGEN INC | $8,816,441 | – | 467,220 | +100.0% | 2.94% | – |
| Sell | DOCEBO INC | $5,492,359 | -13.0% | 138,592 | -10.7% | 1.83% | -22.3% | |
| New | BAUSCH PLUS LOMB CORP | $4,925,800 | – | 245,431 | +100.0% | 1.64% | – | |
| SHC | New | SOTERA HEALTH CO | $4,905,936 | – | 260,400 | +100.0% | 1.63% | – |
| CCK | New | CROWN HLDGS INC | $4,786,537 | – | 55,100 | +100.0% | 1.59% | – |
| FLME | Sell | FLAME ACQUISITION CORP | $4,549,610 | -10.2% | 443,000 | -11.4% | 1.52% | -19.8% |
| QTRX | QUANTERIX CORP | $3,492,995 | +100.1% | 154,900 | 0.0% | 1.16% | +78.6% | |
| WILLIAMS ROWLAND ACQUISITION | $3,079,890 | +1.2% | 297,000 | 0.0% | 1.03% | -9.7% | ||
| New | KNIFE RIVER CORP | $2,966,657 | – | 68,199 | +100.0% | 0.99% | – | |
| RETA | REATA PHARMACEUTICALS INCcl a | $2,528,608 | +12.1% | 24,800 | 0.0% | 0.84% | +0.1% | |
| GOOGL | ALPHABET INCcap stk cl a | $1,663,830 | +15.4% | 13,900 | 0.0% | 0.55% | +3.0% | |
| QURE | New | UNIQURE NV | $1,272,060 | – | 111,000 | +100.0% | 0.42% | – |
| SURROZEN INC | $33,934 | -8.6% | 61,699 | 0.0% | 0.01% | -21.4% | ||
| SURROZEN INC*w exp 08/01/203 | $25,760 | -9.5% | 466,666 | 0.0% | 0.01% | -18.2% | ||
| Exit | WILLIAMS ROWLAND ACQUISITION*w exp 12/11/202 | $0 | – | -475,000 | -100.0% | -0.01% | – | |
| WYNN | Exit | WYNN RESORTS LTD | $0 | – | -4,864 | -100.0% | -0.20% | – |
| Exit | RXSIGHT INC | $0 | – | -99,100 | -100.0% | -0.62% | – | |
| LBRT | Exit | LIBERTY ENERGY INC | $0 | – | -188,000 | -100.0% | -0.90% | – |
| SCHW | Exit | SCHWAB CHARLES CORP | $0 | – | -82,600 | -100.0% | -1.61% | – |
| Exit | BELLRING BRANDS INC | $0 | – | -187,122 | -100.0% | -2.37% | – | |
| MDU | Exit | MDU RES GROUP INC | $0 | – | -272,800 | -100.0% | -3.10% | – |
| VRSN | Exit | VERISIGN INC | $0 | – | -47,300 | -100.0% | -3.73% | – |
| PSPCU | Exit | POST HOLDINGS PARTNERING CORunit 99/99/9999 | $0 | – | -1,250,000 | -100.0% | -4.73% | – |
| ATVI | Exit | ACTIVISION BLIZZARD INC | $0 | – | -158,912 | -100.0% | -5.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.